US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

60 degrees pharmaceuticals, Inc.

1.42

-0.0100-0.70%

Post-market: 1.420.00000.00%18:40 EDT

Volume:42.67K

Turnover:60.63K

Market Cap:5.83M

PE:-0.10

High:1.49

Open:1.49

Low:1.38

Close:1.43

52wk High:12.45

52wk Low:1.22

Shares:4.10M

Float Shares:3.73M

Volume Ratio:0.51

T/O Rate:1.14%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-14.6438

EPS(LYR):-18.5454

ROE:-294.87%

ROA:-113.10%

PB:-0.82

PE(LYR):-0.08

Loading ...

Overview Company News Filings

60 Degrees Pharmaceuticals Inc. Enters New Sales Agreement with H.C. Wainwright & Co

60 Degrees Pharmaceuticals Live Webcast Link and New Date for Presentation at H.C. Wainwright 27th Annual Global Investment Conference

60 Degrees Pharm Is Maintained at Buy by Ascendiant Capital

60 Degrees Pharmaceuticals Inc. Announces Date for Annual Stockholders Meeting

60 Degrees Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference

60 Degrees Pharmaceuticals Selects Icahn School of Medicine at Mount Sinai as Central Clinical Trial Site for Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis

60 Degrees Pharmaceuticals Inc. Announces Date for Annual Meeting of Stockholders

60 Degrees Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership for COO Kristen Landon

60 Degrees Q2 EPS $(1.25) Misses $(0.96) Estimate, Sales $101.000K Miss $301.000K Estimate

60 Degrees Pharmaceuticals Q2 EPS USD -1.25

THOMSON REUTERS

60 Degrees Pharmaceuticals Inc - Expect to Remain Financially Viable Through March 31, 2026

THOMSON REUTERS

60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results

60 Degrees Pharmaceuticals Announces $5 Million Public Offering with Potential Additional $5 Million from Warrant Exercises

60 Degrees Pharmaceuticals and Tulane University Sign Research Agreement to Study Tafenoquine Against Lyme and Bartonella Bacteria

Press Release: 60 Degrees Pharmaceuticals Announces Closing of up to $10 Million Public Offering

60 Degrees Pharmaceuticals to Submit MUMS (Minor Use/Minor Species) Designation Request to FDA for Tafenoquine for Acute Canine Babesiosis in 2025

Director Cheryl Xu Reports Acquisition of Common Shares in 60 Degrees Pharmaceuticals Inc

60 Degrees Pharm Is Maintained at Buy by Ascendiant Capital

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SXTP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SXTP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SXTP\",,,,,undefined,":{"symbol":"SXTP","market":"US","secType":"STK","nameCN":"60 degrees pharmaceuticals, Inc.","latestPrice":1.42,"timestamp":1759521600000,"preClose":1.43,"halted":0,"volume":42665,"hourTrading":{"tag":"盘后","latestPrice":1.42,"preClose":1.42,"latestTime":"18:40 EDT","volume":167,"amount":237.13,"timestamp":1759531235223},"delay":0,"floatShares":3728200,"shares":4104469,"eps":-14.643807,"marketStatus":"Market Closed","change":-0.01,"latestTime":"10-03 16:00:00 EDT","open":1.49,"high":1.49,"low":1.38,"amount":60634.38444350001,"amplitude":0.076923,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-14.643807,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1759737600000},"marketStatusCode":7,"adr":0,"listingDate":1686801600000,"exchange":"NASDAQ","adjPreClose":1.43,"preHourTrading":{"tag":"盘前","latestPrice":1.41,"preClose":1.48,"latestTime":"08:59 EDT","volume":2256,"amount":3192.9598896,"timestamp":1759496395345},"postHourTrading":{"tag":"盘后","latestPrice":1.42,"preClose":1.42,"latestTime":"18:40 EDT","volume":167,"amount":237.13,"timestamp":1759531235223},"volumeRatio":0.5136529570634409},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SXTP\",,,,,undefined,":{"symbol":"SXTP","floatShares":3728200,"roa":"-113.10%","roe":"-294.87%","lyrEps":-18.545406,"volumeRatio":0.5136529570634409,"shares":4104469,"dividePrice":0,"high":1.49,"amplitude":0.076923,"preClose":1.43,"low":1.38,"week52Low":1.215,"pbRate":"-0.82","psRate":"5.92","week52High":12.45,"institutionHeld":0,"latestPrice":1.42,"eps":-14.643807,"divideRate":0,"volume":42665,"delay":0,"ttmEps":-14.643807,"open":1.49,"prevYearClose":6.45,"prevWeekClose":1.36,"prevMonthClose":1.48,"prevQuarterClose":1.48,"fiveDayClose":1.36,"twentyDayClose":1.41,"sixtyDayClose":2.61},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SXTP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-24","symbol":"SXTP","defaultRemindTime":1740407400000,"type":"split","dateTimestamp":1740373200000,"forFactor":5,"toFactor":1,"ratio":5},{"market":"US","date":"2024-08-12","symbol":"SXTP","defaultRemindTime":1723469400000,"type":"split","dateTimestamp":1723435200000,"forFactor":12,"toFactor":1,"ratio":12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SXTP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SXTP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1697860800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SXTP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SXTP","date":"2025-10-03","current":-0.096969,"percent":0.495345,"low":-5.827686,"twenty":-1.458999,"median":-0.74578,"eighty":-0.383184,"high":-0.148542,"avg":-1.064301,"sd":1.056951,"marketCap":5869390},"quantilePoints":[{"date":"2023-07-14","current":-3.206044,"twenty":-3.575483,"median":-3.312205,"eighty":-3.248508,"marketCap":25229961},{"date":"2023-07-21","current":-2.066589,"twenty":-3.269741,"median":-2.519541,"eighty":-2.109053,"marketCap":16263021},{"date":"2023-07-28","current":-1.549942,"twenty":-3.005047,"median":-2.066589,"eighty":-1.612223,"marketCap":12197266},{"date":"2023-08-04","current":-1.436704,"twenty":-2.556343,"median":-1.68795,"eighty":-1.51314,"marketCap":11306141},{"date":"2023-08-11","current":-1.082836,"twenty":-2.270417,"median":-1.578251,"eighty":-1.364515,"marketCap":8521377},{"date":"2023-08-18","current":-1.132378,"twenty":-2.130285,"median":-1.514555,"eighty":-1.186166,"marketCap":8911244},{"date":"2023-08-25","current":-1.075759,"twenty":-1.995815,"median":-1.493323,"eighty":-1.119638,"marketCap":8465682},{"date":"2023-09-01","current":-0.896195,"twenty":-1.818881,"median":-1.298696,"eighty":-1.075759,"marketCap":8118769},{"date":"2023-09-08","current":-0.774624,"twenty":-1.702813,"median":-1.231461,"eighty":-0.96014,"marketCap":7017437},{"date":"2023-09-15","current":-0.729811,"twenty":-1.64761,"median":-1.146532,"eighty":-0.891125,"marketCap":6611469},{"date":"2023-09-22","current":-0.512148,"twenty":-1.583913,"median":-1.121762,"eighty":-0.799591,"marketCap":4639628},{"date":"2023-09-29","current":-0.473737,"twenty":-1.572589,"median":-1.082836,"eighty":-0.74506,"marketCap":4291655},{"date":"2023-10-06","current":-0.428924,"twenty":-1.54428,"median":-1.043911,"eighty":-0.582824,"marketCap":3885688},{"date":"2023-10-13","current":-0.449858,"twenty":-1.518801,"median":-0.952467,"eighty":-0.507026,"marketCap":4075333},{"date":"2023-10-20","current":-0.524952,"twenty":-1.507478,"median":-0.898787,"eighty":-0.48823,"marketCap":4755618},{"date":"2023-10-27","current":-0.423162,"twenty":-1.507478,"median":-0.893026,"eighty":-0.483288,"marketCap":3833492},{"date":"2023-11-03","current":-0.377709,"twenty":-1.498985,"median":-0.86425,"eighty":-0.474121,"marketCap":3421725},{"date":"2023-11-10","current":-0.384111,"twenty":-1.459352,"median":-0.781026,"eighty":-0.464774,"marketCap":3479721},{"date":"2023-11-17","current":-0.435326,"twenty":-1.364515,"median":-0.768158,"eighty":-0.451894,"marketCap":3943683},{"date":"2023-11-24","current":-0.957437,"twenty":-1.302234,"median":-0.768222,"eighty":-0.451215,"marketCap":3282536},{"date":"2023-12-01","current":-1.048783,"twenty":-1.272509,"median":-0.817837,"eighty":-0.455018,"marketCap":3595711},{"date":"2023-12-08","current":-1.126596,"twenty":-1.237122,"median":-0.883455,"eighty":-0.458974,"marketCap":3862490},{"date":"2023-12-15","current":-1.209483,"twenty":-1.239655,"median":-0.898787,"eighty":-0.463494,"marketCap":4146667},{"date":"2023-12-22","current":-1.860743,"twenty":-1.313345,"median":-0.952467,"eighty":-0.469896,"marketCap":6379488},{"date":"2023-12-29","current":-1.877659,"twenty":-1.436704,"median":-0.957437,"eighty":-0.473737,"marketCap":6437483},{"date":"2024-01-05","current":-1.843828,"twenty":-1.498985,"median":-0.99083,"eighty":-0.473737,"marketCap":6321493},{"date":"2024-01-12","current":-1.684903,"twenty":-1.535158,"median":-1.005049,"eighty":-0.473737,"marketCap":5776626},{"date":"2024-01-19","current":-1.239932,"twenty":-1.578554,"median":-1.044215,"eighty":-0.473993,"marketCap":4251059},{"date":"2024-01-26","current":-0.829046,"twenty":-1.566927,"median":-1.048783,"eighty":-0.474761,"marketCap":2842352},{"date":"2024-02-02","current":-0.925149,"twenty":-1.540086,"median":-1.013507,"eighty":-0.475465,"marketCap":3171838},{"date":"2024-02-09","current":-0.910618,"twenty":-1.523834,"median":-0.998035,"eighty":-0.47745,"marketCap":3122019},{"date":"2024-02-16","current":-1.032034,"twenty":-1.51597,"median":-0.998035,"eighty":-0.482239,"marketCap":3538288},{"date":"2024-02-23","current":-0.952597,"twenty":-1.507478,"median":-0.999534,"eighty":-0.485478,"marketCap":3265942},{"date":"2024-03-01","current":-0.872837,"twenty":-1.504647,"median":-0.997482,"eighty":-0.487014,"marketCap":2992488},{"date":"2024-03-08","current":-0.96067,"twenty":-1.485273,"median":-0.987859,"eighty":-0.492942,"marketCap":3293619},{"date":"2024-03-15","current":-0.79114,"twenty":-1.449798,"median":-0.959539,"eighty":-0.498115,"marketCap":2712392},{"date":"2024-03-22","current":-0.916107,"twenty":-1.420017,"median":-0.955017,"eighty":-0.500624,"marketCap":3140839},{"date":"2024-03-28","current":-0.855077,"twenty":-1.353268,"median":-0.952532,"eighty":-0.505746,"marketCap":2931598},{"date":"2024-04-05","current":-0.849647,"twenty":-1.338044,"median":-0.936451,"eighty":-0.512148,"marketCap":3199516},{"date":"2024-04-12","current":-0.816395,"twenty":-1.316389,"median":-0.933222,"eighty":-0.524952,"marketCap":3074302},{"date":"2024-04-19","current":-0.757247,"twenty":-1.308779,"median":-0.92967,"eighty":-0.530713,"marketCap":2851568},{"date":"2024-04-26","current":-0.717764,"twenty":-1.281002,"median":-0.922727,"eighty":-0.537755,"marketCap":2702887},{"date":"2024-05-03","current":-0.712848,"twenty":-1.27038,"median":-0.915462,"eighty":-0.550879,"marketCap":2684374},{"date":"2024-05-10","current":-0.706703,"twenty":-1.25977,"median":-0.903415,"eighty":-0.619133,"marketCap":2661232},{"date":"2024-05-17","current":-3.509711,"twenty":-1.27038,"median":-0.90138,"eighty":-0.641256,"marketCap":2580238},{"date":"2024-05-24","current":-4.594449,"twenty":-1.338044,"median":-0.91304,"eighty":-0.64525,"marketCap":3377706},{"date":"2024-05-31","current":-4.661966,"twenty":-1.461121,"median":-0.918206,"eighty":-0.666636,"marketCap":3427342},{"date":"2024-06-07","current":-5.728069,"twenty":-1.522366,"median":-0.927087,"eighty":-0.675178,"marketCap":4211110},{"date":"2024-06-14","current":-4.678752,"twenty":-1.578453,"median":-0.931607,"eighty":-0.675977,"marketCap":3439683},{"date":"2024-06-21","current":-4.565851,"twenty":-1.664999,"median":-0.933222,"eighty":-0.682122,"marketCap":3356681},{"date":"2024-06-28","current":-4.459591,"twenty":-1.683685,"median":-0.93467,"eighty":-0.688267,"marketCap":3278562},{"date":"2024-07-05","current":-3.848597,"twenty":-1.749099,"median":-0.942586,"eighty":-0.700189,"marketCap":2829377},{"date":"2024-07-12","current":-4.084361,"twenty":-1.843828,"median":-0.952597,"eighty":-0.706457,"marketCap":3002704},{"date":"2024-07-15","current":-4.07606,"twenty":-1.847211,"median":-0.952597,"eighty":-0.70658,"marketCap":2996601},{"date":"2024-08-02","current":-2.282925,"twenty":-1.860743,"median":-0.955017,"eighty":-0.706703,"marketCap":1678340},{"date":"2024-08-09","current":-1.534126,"twenty":-1.877659,"median":-0.959539,"eighty":-0.710605,"marketCap":1127845},{"date":"2024-08-16","current":-1.068072,"twenty":-1.877659,"median":-0.987859,"eighty":-0.712848,"marketCap":1678338},{"date":"2024-08-23","current":-2.160665,"twenty":-1.877659,"median":-0.997482,"eighty":-0.717764,"marketCap":3395207},{"date":"2024-08-30","current":-1.710527,"twenty":-1.890582,"median":-0.999534,"eighty":-0.729811,"marketCap":2687872},{"date":"2024-09-06","current":-1.620499,"twenty":-1.88984,"median":-1.0072,"eighty":-0.729811,"marketCap":2546405},{"date":"2024-09-13","current":-1.530471,"twenty":-1.880058,"median":-1.014951,"eighty":-0.730006,"marketCap":2404938},{"date":"2024-09-20","current":-1.521468,"twenty":-1.877659,"median":-1.04133,"eighty":-0.731038,"marketCap":2390791},{"date":"2024-09-27","current":-1.468799,"twenty":-1.869809,"median":-1.049471,"eighty":-0.737686,"marketCap":2308028},{"date":"2024-10-04","current":-1.255991,"twenty":-1.862164,"median":-1.066844,"eighty":-0.740259,"marketCap":1973628},{"date":"2024-10-11","current":-1.244142,"twenty":-1.847211,"median":-1.075002,"eighty":-0.740502,"marketCap":1955009},{"date":"2024-10-18","current":-1.232293,"twenty":-1.843828,"median":-1.079298,"eighty":-0.743697,"marketCap":1936390},{"date":"2024-10-25","current":-1.016642,"twenty":-1.840904,"median":-1.082836,"eighty":-0.754697,"marketCap":1597522},{"date":"2024-10-31","current":-0.975171,"twenty":-1.832216,"median":-1.075759,"eighty":-0.763051,"marketCap":1532355},{"date":"2024-11-08","current":-1.26784,"twenty":-1.806613,"median":-1.075381,"eighty":-0.767663,"marketCap":1992247},{"date":"2024-11-15","current":-1.125653,"twenty":-1.78406,"median":-1.082836,"eighty":-0.768196,"marketCap":1768818},{"date":"2024-11-22","current":-0.205615,"twenty":-1.766768,"median":-1.075381,"eighty":-0.742898,"marketCap":1627312},{"date":"2024-11-29","current":-0.307708,"twenty":-1.757765,"median":-1.071273,"eighty":-0.734485,"marketCap":2435312},{"date":"2024-12-06","current":-0.345446,"twenty":-1.750257,"median":-1.065617,"eighty":-0.722583,"marketCap":2733983},{"date":"2024-12-13","current":-0.47898,"twenty":-1.738613,"median":-1.055566,"eighty":-0.706334,"marketCap":3790817},{"date":"2024-12-20","current":-0.40931,"twenty":-1.727188,"median":-1.048783,"eighty":-0.67358,"marketCap":3239425},{"date":"2024-12-27","current":-0.38899,"twenty":-1.717281,"median":-1.039648,"eighty":-0.641313,"marketCap":3078603},{"date":"2025-01-03","current":-0.380281,"twenty":-1.712721,"median":-1.016642,"eighty":-0.550879,"marketCap":3009679},{"date":"2025-01-10","current":-0.316417,"twenty":-1.710966,"median":-1.012063,"eighty":-0.522391,"marketCap":2504236},{"date":"2025-01-17","current":-0.239606,"twenty":-1.690028,"median":-1.00281,"eighty":-0.496592,"marketCap":1896327},{"date":"2025-01-24","current":-0.255137,"twenty":-1.68399,"median":-0.998035,"eighty":-0.483288,"marketCap":2019241},{"date":"2025-01-31","current":-0.232233,"twenty":-1.673079,"median":-0.992315,"eighty":-0.474953,"marketCap":1837972},{"date":"2025-02-07","current":-0.153564,"twenty":-1.664392,"median":-0.980029,"eighty":-0.471176,"marketCap":1215358},{"date":"2025-02-14","current":-0.582606,"twenty":-1.637571,"median":-0.96067,"eighty":-0.473737,"marketCap":4610947},{"date":"2025-02-21","current":-0.439583,"twenty":-1.620499,"median":-0.957437,"eighty":-0.473737,"marketCap":3479015},{"date":"2025-02-28","current":-0.349879,"twenty":-1.606995,"median":-0.952597,"eighty":-0.455018,"marketCap":2769070},{"date":"2025-03-07","current":-0.295909,"twenty":-1.586175,"median":-0.942586,"eighty":-0.438837,"marketCap":2341926},{"date":"2025-03-14","current":-0.325686,"twenty":-1.5827,"median":-0.933946,"eighty":-0.428924,"marketCap":2577592},{"date":"2025-03-21","current":-0.36849,"twenty":-1.578554,"median":-0.931607,"eighty":-0.419612,"marketCap":2916361},{"date":"2025-03-28","current":-0.338713,"twenty":-1.572643,"median":-0.927312,"eighty":-0.40931,"marketCap":2680696},{"date":"2025-04-04","current":-0.34102,"twenty":-1.562151,"median":-0.925149,"eighty":-0.394645,"marketCap":2710119},{"date":"2025-04-11","current":-0.574544,"twenty":-1.556789,"median":-0.915785,"eighty":-0.39251,"marketCap":4565962},{"date":"2025-04-17","current":-0.587517,"twenty":-1.553338,"median":-0.908035,"eighty":-0.394595,"marketCap":4669064},{"date":"2025-04-25","current":-0.543037,"twenty":-1.552371,"median":-0.898993,"eighty":-0.395957,"marketCap":4315570},{"date":"2025-05-02","current":-0.459635,"twenty":-1.549767,"median":-0.893026,"eighty":-0.401762,"marketCap":3652769},{"date":"2025-05-09","current":-0.418861,"twenty":-1.547598,"median":-0.874888,"eighty":-0.406988,"marketCap":3328733},{"date":"2025-05-16","current":-0.398474,"twenty":-1.541724,"median":-0.870254,"eighty":-0.406988,"marketCap":3166715},{"date":"2025-05-23","current":-0.323906,"twenty":-1.541274,"median":-0.86425,"eighty":-0.394595,"marketCap":3321369},{"date":"2025-05-30","current":-0.382079,"twenty":-1.539474,"median":-0.855077,"eighty":-0.384111,"marketCap":3917890},{"date":"2025-06-06","current":-0.425171,"twenty":-1.534126,"median":-0.848946,"eighty":-0.384111,"marketCap":4359757},{"date":"2025-06-13","current":-0.327497,"twenty":-1.530471,"median":-0.844971,"eighty":-0.384111,"marketCap":3358191},{"date":"2025-06-20","current":-0.31026,"twenty":-1.530471,"median":-0.840362,"eighty":-0.383346,"marketCap":3181444},{"date":"2025-06-27","current":-0.350479,"twenty":-1.530471,"median":-0.828469,"eighty":-0.382076,"marketCap":3593854},{"date":"2025-07-03","current":-0.34186,"twenty":-1.52737,"median":-0.817007,"eighty":-0.376415,"marketCap":3505480},{"date":"2025-07-11","current":-0.374897,"twenty":-1.5231,"median":-0.815166,"eighty":-0.372679,"marketCap":3844245},{"date":"2025-07-18","current":-0.475084,"twenty":-1.521534,"median":-0.809921,"eighty":-0.369678,"marketCap":4871569},{"date":"2025-07-25","current":-0.421598,"twenty":-1.513366,"median":-0.799667,"eighty":-0.370493,"marketCap":4323114},{"date":"2025-08-01","current":-0.421598,"twenty":-1.507672,"median":-0.795011,"eighty":-0.372679,"marketCap":4323114},{"date":"2025-08-08","current":-0.415305,"twenty":-1.507478,"median":-0.778869,"eighty":-0.374314,"marketCap":4258590},{"date":"2025-08-15","current":-0.688009,"twenty":-1.505883,"median":-0.772764,"eighty":-0.374475,"marketCap":5376854},{"date":"2025-08-22","current":-0.682757,"twenty":-1.499955,"median":-0.768222,"eighty":-0.374728,"marketCap":5335809},{"date":"2025-08-29","current":-0.682757,"twenty":-1.494678,"median":-0.762084,"eighty":-0.376584,"marketCap":5335809},{"date":"2025-09-05","current":-0.777292,"twenty":-1.488443,"median":-0.762018,"eighty":-0.378738,"marketCap":6074614},{"date":"2025-09-12","current":-0.74578,"twenty":-1.476193,"median":-0.74578,"eighty":-0.380993,"marketCap":5828345},{"date":"2025-09-19","current":-0.766788,"twenty":-1.46646,"median":-0.748406,"eighty":-0.382069,"marketCap":5992524},{"date":"2025-09-26","current":-0.730024,"twenty":-1.462951,"median":-0.74578,"eighty":-0.382521,"marketCap":5705211},{"date":"2025-10-03","current":-0.751032,"twenty":-1.458999,"median":-0.74578,"eighty":-0.383184,"marketCap":5869390}],"updateTime":1759677895057},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SXTP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2565593678","title":"60 Degrees Pharmaceuticals Inc. Enters New Sales Agreement with H.C. Wainwright & Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2565593678","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565593678?lang=en_us&edition=fundamental","pubTime":"2025-09-06 04:21","pubTimestamp":1757103684,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals Inc. has entered into a new At-The-Market Sales Agreement with H.C. Wainwright & Co., LLC as of September 3, 2025. This agreement allows the company to offer and sell shares of its common stock, with a total potential gross sales value of up to $1,397,533, through Wainwright acting as a sales agent or principal. The move follows the termination of a previous similar agreement with Wallachbeth Capital LLC, effective the same day. The sales under the new agreement will be conducted pursuant to the company's shelf registration statement filed with the SEC.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 60 Degrees Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250905:nNDL8sbzLy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP"],"gpt_icon":0},{"id":"2564639329","title":"60 Degrees Pharmaceuticals Live Webcast Link and New Date for Presentation at H.C. Wainwright 27th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2564639329","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564639329?lang=en_us&edition=fundamental","pubTime":"2025-09-03 20:02","pubTimestamp":1756900920,"startTime":"0","endTime":"0","summary":"WASHINGTON, Sept.  03, 2025  (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new medic","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/03/3143571/0/en/60-Degrees-Pharmaceuticals-Live-Webcast-Link-and-New-Date-for-Presentation-at-H-C-Wainwright-27th-Annual-Global-Investment-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP"],"gpt_icon":0},{"id":"2564136753","title":"60 Degrees Pharm Is Maintained at Buy by Ascendiant Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2564136753","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564136753?lang=en_us&edition=fundamental","pubTime":"2025-09-03 18:55","pubTimestamp":1756896900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SXTP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 03, 2025 06:55 ET (10:55 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP"],"gpt_icon":0},{"id":"2562714087","title":"60 Degrees Pharmaceuticals Inc. Announces Date for Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2562714087","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562714087?lang=en_us&edition=fundamental","pubTime":"2025-08-27 18:04","pubTimestamp":1756289060,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals Inc. will hold its 2024 Annual Meeting of Stockholders on October 8, 2025. The meeting will be conducted via live audio webcast. The Board of Directors is not aware of any matters that are expected to come before the meeting other than those referred to in the proxy statement. If any other matter should arise, the proxies will be voted according to the best judgment of the individuals named on the proxy card.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 60 Degrees Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 27, 2025, and is sole","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250827:nNDL6prwCb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP"],"gpt_icon":0},{"id":"2561498413","title":"60 Degrees Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2561498413","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561498413?lang=en_us&edition=fundamental","pubTime":"2025-08-21 20:31","pubTimestamp":1755779460,"startTime":"0","endTime":"0","summary":"WASHINGTON, Aug.  21, 2025  (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new medici","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/21/3137147/0/en/60-Degrees-Pharmaceuticals-to-Present-at-H-C-Wainwright-27th-Annual-Global-Investment-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2560949551","title":"60 Degrees Pharmaceuticals Selects Icahn School of Medicine at Mount Sinai as Central Clinical Trial Site for Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2560949551","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560949551?lang=en_us&edition=fundamental","pubTime":"2025-08-19 20:54","pubTimestamp":1755608040,"startTime":"0","endTime":"0","summary":"90-day trial measuring change in general fatigue in chronic babesiosis patientsEnrollment expected to commence Q4 2025 and to be completed by Q2 2026Site has clinical expertise in infectious disease t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/19/3135722/0/en/60-Degrees-Pharmaceuticals-Selects-Icahn-School-of-Medicine-at-Mount-Sinai-as-Central-Clinical-Trial-Site-for-Phase-II-Study-to-Evaluate-Tafenoquine-for-Chronic-Babesiosis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP"],"gpt_icon":0},{"id":"2559394688","title":"60 Degrees Pharmaceuticals Inc. Announces Date for Annual Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2559394688","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559394688?lang=en_us&edition=fundamental","pubTime":"2025-08-16 04:07","pubTimestamp":1755288430,"startTime":"0","endTime":"0","summary":"Washington, D.C. - 60 Degrees Pharmaceuticals, Inc. has announced that its Annual Meeting of Stockholders will be held on October 8, 2025. The meeting will be conducted via live audio webcast. While the specific proposals or resolutions to be voted on during the meeting were not disclosed, the Board of Directors encourages all stockholders of record as of August 29, 2025, to participate in the meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 60 Degrees Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 15, 2025, and is solely responsible for the information","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nNDL9k2ZV1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2559995311","title":"60 Degrees Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership for COO Kristen Landon","url":"https://stock-news.laohu8.com/highlight/detail?id=2559995311","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559995311?lang=en_us&edition=fundamental","pubTime":"2025-08-15 09:23","pubTimestamp":1755221020,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals Inc. has filed an initial statement of beneficial ownership. Kristen Landon, serving as the Chief Operating Officer, is identified as the beneficial owner in this filing. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 60 Degrees Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 14, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nNDL5trNXC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2559989028","title":"60 Degrees Q2 EPS $(1.25) Misses $(0.96) Estimate, Sales $101.000K Miss $301.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2559989028","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559989028?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:19","pubTimestamp":1755116358,"startTime":"0","endTime":"0","summary":"60 Degrees (NASDAQ:SXTP) reported quarterly losses of $(1.25) per share which missed the analyst consensus estimate of $(0.96) by 30.21 percent. This is a 70.45 percent increase over losses of $(4.23) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47106689/60-degrees-q2-eps-1-25-misses-0-96-estimate-sales-101-000k-miss-301-000k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"60 Degrees Q2 EPS $(1.25) Misses $(0.96) Estimate, Sales $101.000K Miss $301.000K Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP"],"gpt_icon":0},{"id":"2559989795","title":"60 Degrees Pharmaceuticals Q2 EPS USD -1.25","url":"https://stock-news.laohu8.com/highlight/detail?id=2559989795","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559989795?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:14","pubTimestamp":1755116072,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nPLX78113D:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SXTP"],"gpt_icon":0},{"id":"2559198971","title":"60 Degrees Pharmaceuticals Inc - Expect to Remain Financially Viable Through March 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2559198971","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559198971?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:14","pubTimestamp":1755116072,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nPLX78113D:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2559811689","title":"60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2559811689","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559811689?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:14","pubTimestamp":1755116040,"startTime":"0","endTime":"0","summary":"A now resolved supply disruption led to Q2 net product revenue decline but higher profitability due to increased usage of a cash-pay distribution model$1.97 million cash on hand, runway through March ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/13/3132999/0/en/60-Degrees-Pharmaceuticals-Announces-Second-Quarter-2025-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2552449096","title":"60 Degrees Pharmaceuticals Announces $5 Million Public Offering with Potential Additional $5 Million from Warrant Exercises","url":"https://stock-news.laohu8.com/highlight/detail?id=2552449096","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552449096?lang=en_us&edition=fundamental","pubTime":"2025-07-19 04:58","pubTimestamp":1752872309,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals Inc., a company focused on developing new medicines for infectious diseases, has announced the pricing of a public offering involving 2,631,578 shares of its common stock. This offering includes accompanying Series A-1 warrants and short-term Series A-2 warrants to purchase an equal number of shares, priced at $1.90 per share of common stock. The company anticipates gross proceeds of approximately $5 million from the offering, with the possibility of an additional $5 million if the short-term Series A-2 warrants are fully exercised on a cash basis. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering. The proceeds are intended for working capital and general corporate purposes.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250718:nNDL1wyyX8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2552489961","title":"60 Degrees Pharmaceuticals and Tulane University Sign Research Agreement to Study Tafenoquine Against Lyme and Bartonella Bacteria","url":"https://stock-news.laohu8.com/highlight/detail?id=2552489961","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552489961?lang=en_us&edition=fundamental","pubTime":"2025-07-17 20:01","pubTimestamp":1752753660,"startTime":"0","endTime":"0","summary":"Study will evaluate activity of tafenoquine against vector-borne pathogens, Borrelia (Lyme disease) and Bartonella in cell cultureBorrelia and Bartonella, together with Babesia, represent the \"3Bs,\" p","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/17/3117175/0/en/60-Degrees-Pharmaceuticals-and-Tulane-University-Sign-Research-Agreement-to-Study-Tafenoquine-Against-Lyme-and-Bartonella-Bacteria.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1878469433.USD","ALT","SXTP","BK4007","BK4599"],"gpt_icon":0},{"id":"2552786831","title":"Press Release: 60 Degrees Pharmaceuticals Announces Closing of up to $10 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2552786831","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552786831?lang=en_us&edition=fundamental","pubTime":"2025-07-17 04:01","pubTimestamp":1752696060,"startTime":"0","endTime":"0","summary":"WASHINGTON, July 16, 2025  -- 60 Degrees Pharmaceuticals, Inc.  , a pharmaceutical company focused on developing new medicines for infectious diseases, today announced the closing of its previously announced public offering of 2,631,578 shares of the Company's common stock  and accompanying Series A-1 warrants to purchase up to 2,631,578 shares of common stock and short-term Series A-2 warrants to purchase up to 2,631,578 shares of common stock, at a combined offering price of $1.90 per share of common stock  and accompanying warrants.The Series A-1 warrants have an exercise price of $1.90 per share, are exercisable upon issuance and expire five years thereafter. The short-term Series A-2 warrants have an exercise price of $1.90 per share, are exercisable upon issuance and expire 18 months thereafter.60 Degrees Pharmaceuticals, Inc., founded in 2010, specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases that affect the lives of mi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","R","BK4007","BK4022","SXTP"],"gpt_icon":0},{"id":"2551135953","title":"60 Degrees Pharmaceuticals to Submit MUMS (Minor Use/Minor Species) Designation Request to FDA for Tafenoquine for Acute Canine Babesiosis in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2551135953","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551135953?lang=en_us&edition=fundamental","pubTime":"2025-07-15 04:01","pubTimestamp":1752523260,"startTime":"0","endTime":"0","summary":"Data from three independent clinical studies demonstrate utility of tafenoquine to treat acute canine babesiosis WASHINGTON, July  14, 2025  (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc.(NASDAQ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/14/3115142/0/en/60-Degrees-Pharmaceuticals-to-Submit-MUMS-Minor-Use-Minor-Species-Designation-Request-to-FDA-for-Tafenoquine-for-Acute-Canine-Babesiosis-in-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","LU1363072403.SGD","LU0882574139.USD","BK4007","BK4139","LU1878469433.USD","LU0170899867.USD","ALT","IE00B1BXHZ80.USD","IE00BHPRN162.USD","IE00BKVL7J92.USD","BK4599","LU0149725797.USD","LU0267386448.USD","CMC","IE00BZ1G4Q59.USD","BK4006","LU0971096721.USD"],"gpt_icon":0},{"id":"2541100724","title":"Director Cheryl Xu Reports Acquisition of Common Shares in 60 Degrees Pharmaceuticals Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2541100724","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541100724?lang=en_us&edition=fundamental","pubTime":"2025-06-06 08:53","pubTimestamp":1749171217,"startTime":"0","endTime":"0","summary":"Cheryl Xu, a Director at 60 Degrees Pharmaceuticals Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 60 Degrees Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250606:nNDL9gm9R9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director Cheryl Xu Reports Acquisition of Common Shares in 60 Degrees Pharmaceuticals Inc","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP"],"gpt_icon":0},{"id":"2540769761","title":"60 Degrees Pharm Is Maintained at Buy by Ascendiant Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2540769761","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540769761?lang=en_us&edition=fundamental","pubTime":"2025-06-02 17:52","pubTimestamp":1748857920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SXTP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 02, 2025 05:52 ET (09:52 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":29,"code":"91000000","status":"200"}]}}